S-nitrosylation in health and disease

https://doi.org/10.1016/S1471-4914(03)00028-5Get rights and content

Abstract

S-nitrosylation is a ubiquitous redox-related modification of cysteine thiol by nitric oxide (NO), which transduces NO bioactivity. Accumulating evidence suggests that the products of S-nitrosylation, S-nitrosothiols (SNOs), play key roles in human health and disease. In this review, we focus on the reaction mechanisms underlying the biological responses mediated by SNOs. We emphasize reactions that can be identified with complex (patho)physiological responses, and that best rationalize the observed increase or decrease in specific classes of SNOs across a spectrum of disease states. Thus, changes in the levels of various SNOs depend on specific defects in both enzymatic and non-enzymatic mechanisms of nitrosothiol formation, processing and degradation. An understanding of these mechanisms is crucial for the development of an integrated model of NO biology, and for effective treatment of diseases associated with dysregulation of NO homeostasis.

Section snippets

Molecular mechanism versus integrated (patho)physiological model

The distinguishing feature of S-nitrosylation compared with other post-translational protein modifications (e.g. phosphorylation and glycosylation) is that no single or even general reaction applies; the reaction mechanism (molecular-level behavior) is largely a function of the peptide or protein being modified. Moreover, the mechanism can change as a function of the concentration of reactants and the redox state of the system. Thus, in any discussion of SNO biology (integrated system), the

S-nitrosylation by NOS

Although NOS activity is associated with many physiological responses, few of the crucial protein targets are known and the molecular details are poorly defined. However, all isoforms of NOS, as well as all physiological stimuli that activate NOSs, lead to nitrosative chemistry and thus to S-nitrosylation. In vivo imaging of cells using the fluorogenic NO+ scavenger, 4,5-diaminofluorescein, has revealed that NOS localization and activation are spatially coincident and co-temporal with

Coupling of blood flow and breathing

Endothelium-dependent relaxation of blood vessels regulates blood flow in response to shear stress, and is mediated through both cGMP production and S-nitrosylaton of key ion channels [3]. By contrast, red blood cells (RBCs) mediate hypoxic vasodilation: they act as a vehicle for O2-regulated delivery of NO signals, in the form of SNOs (hypoxic vasodilation is not blocked by NOS inhibitors). In particular, human hemoglobin (Hb) has been shown to bind and convert NO to bioactive nitrosothiol (at

Tuning of blood pressure, blood clotting and muscle contractility

In an aqueous environment, reaction of NO with dioxygen proceeds via dinitrogen trioxide (N2O3), a potent nitrosating agent. N2O3 can nitrosate thiols, implicating this species in protein S-nitrosylation under aerobic conditions. Auto-oxidation is slow on a physiological timescale, but because NO and O2 have up to ten times greater solubilities in hydrophobic environments than in water [38], their partitioning within biological membranes and hydrophobic compartments is predicted to accelerate N2

Sensing and signaling: tactile stimuli, hypoxia and nitrosative stress

Transnitros(yl)ation is invoked in the physiological responses to small-molecule SNOs that are not reproduced by NO itself. Thus, this mechanism is implicated in the effects of somatosensory afferent stimulation (which produces CysGlyNO [46]) and in the role of GSNO (or CysNO/CysGlyNO) in triggering hypoxic ventilation [26]. Transnitrosylation is arguably the only chemical reaction involving NO that has been shown by stringent genetic criteria to occur in vivo. Mouse hepatocytes lacking GSNO

Physiology (blood and gut) and pathology (ischemia and asthma)

Resident nitrite (NO2), acquired through dietary uptake and NOS activity, might serve as an alternative source of NO bioactivity and S-nitrosylation in low pH conditions, such as in the stomach and the asthmatic airway [56]. This reaction mechanism could have evolved to protect against microbial pathogens encountered in the gut, and to recycle NO bioactivity. NO synthesis from NO2 is also predicted to increase 100-fold in ischemic tissue (pH 5.5), compared with normally perfused tissue (pH

Plasma SNOs, hemostasis and hypercholesterolemia

In the plasma, copper-mediated catalysis of S-nitrosylation might be a relevant mechanism for generating bioactive SNOs. Copper binds BSA at Cys34 and catalyzes S-nitrosylation of this residue by NO [59]. Copper either oxidizes NO· to NO+ or generates a thiyl-radical intermediate that subsequently reacts with NO· directly (Table 3). It is possible that at physiological plasma NO concentrations (perhaps 1–10 nM), metal catalysis dominates the more widely studied auto-oxidation and

Elevated nitrosothiols (nitrosative stress)

Excessive SNO, either systemic or local, has been detected by a variety of techniques in patients with inflammatory and autoimmune diseases. However, the link between increased SNO synthesis and the development of pathology requires further study in each case. Indeed, a protective or compensatory role of SNOs is possible, including antimicrobial functions and the diversion of toxic NO-related species to a more inert form, as suggested by the accumulation of antimicrobial SNOs in the blood of

Depletion of nitrosothiols

The mechanisms by which nitrosothiols are degraded are of key importance to the understanding of S-nitrosylation in health and disease. The release of SNO-metabolizing enzymes and other transition-metal-containing proteins from injured cells, during preparatory techniques or disease, might contribute to observed variances in SNO levels (physiological variations as well as experimental artefacts, notwithstanding other differences in methods, sample processing and techniques). In particular,

SNO therapy

Inhaled NO gas (iNO) provides important therapeutic benefits to babies with persistent pulmonary hypertension of the newborn, although concerns about toxicity remain. However, iNO therapy is harder to rationalize in diseases such as asthma and adult respiratory distress syndrome (ARDS), which present with clinical signs of NO deficiency (airway constriction and V/Q mismatching), but are actually characterized by elevated NO production. In addition, the deficiency of NO bioactivity that promotes

References (88)

  • D Jourd'heuil

    S-nitrosothiol formation in blood of lipopolysaccharide-treated rats

    Biochem. Biophys. Res. Commun.

    (2000)
  • M.S Crane

    Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function

    J. Biol. Chem.

    (2002)
  • T.J McMahon

    Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin

    J. Biol. Chem.

    (2000)
  • J.S Stamler

    (S)NO signals: translocation, regulation, and a consensus motif

    Neuron

    (1997)
  • M Boese

    S-nitrosation of serum albumin by dinitrosyl-iron complex

    J. Biol. Chem.

    (1995)
  • A Mulsch

    Formation and release of dinitrosyl iron complexes by endothelial cells

    Biochem. Biophys. Res. Commun.

    (1993)
  • A.F Vanin

    The relationship between l-arginine-dependent nitric oxide synthesis, nitrite release and dinitrosyl-iron complex formation by activated macrophages

    Biochim. Biophys. Acta

    (1993)
  • E Weitzberg et al.

    Nonenzymatic nitric oxide production in humans

    Nitric Oxide

    (1998)
  • J.L Zweier

    Non-enzymatic nitric oxide synthesis in biological systems

    Biochim. Biophys. Acta

    (1999)
  • A.V Kozlov

    Nitrite reductase activity is a novel function of mammalian mitochondria

    FEBS Lett.

    (1999)
  • G Stubauer

    Mechanism of S-nitrosothiol formation and degradation mediated by copper ions

    J. Biol. Chem.

    (1999)
  • K Inoue

    Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo

    J. Biol. Chem.

    (1999)
  • P Moriel

    Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?

    Free Radic. Biol. Med.

    (2001)
  • A.I Boullerne

    Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine

    J. Neuroimmunol.

    (1995)
  • M.L Ferrier

    Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis

    Kidney Int.

    (2001)
  • L.H Ottesen

    Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia

    Free Radic. Biol. Med.

    (2001)
  • B Gaston

    Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure

    Lancet

    (1998)
  • M.A Johnson

    Accelerated S-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutase

    J. Biol. Chem.

    (2001)
  • H Grasemann

    Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function

    J. Pediatr.

    (1999)
  • C Andersson

    S-Nitrosoglutathione induces functional ΔF508-CFTR in airway epithelial cells

    Biochem. Biophys. Res. Commun.

    (2002)
  • M.P Moya

    Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn

    Lancet

    (2002)
  • C Bonaventura

    Heme redox properties of S-nitrosated hemoglobin A0 and hemoglobin S: implications for interactions of nitric oxide with normal and sickle red blood cells

    J. Biol. Chem.

    (2002)
  • A.J Gow

    A novel reaction mechanism for the formation of S-nitrosothiol in vivo

    J. Biol. Chem.

    (1997)
  • M Stoll

    A genomic-systems biology map for cardiovascular function

    Science

    (2001)
  • V.M Bolotina

    Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle

    Nature

    (1994)
  • J.P Eu

    An apoptotic model for nitrosative stress

    Biochemistry

    (2000)
  • M Gonzalez-Zulueta

    Requirement for nitric oxide activation of p21ras/extracellular regulated kinase in neuronal ischemic preconditioning

    Proc. Natl. Acad. Sci. U. S. A.

    (2000)
  • S Dimmeler et al.

    Nitric oxide – an endothelial cell survival factor

    Cell Death Differ.

    (1999)
  • J.B Mannick

    Fas-induced caspase denitrosylation

    Science

    (1999)
  • T.S Lai

    Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase

    Biochemistry

    (2001)
  • L Jia

    S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control

    Nature

    (1996)
  • T Nagano et al.

    Bioimaging of nitric oxide

    Chem. Rev.

    (2002)
  • L Xu

    Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation

    Science

    (1998)
  • S.R Jaffrey

    Protein S-nitrosylation: a physiological signal for neuronal nitric oxide

    Nat. Cell Biol.

    (2001)
  • Cited by (0)

    View full text